Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 5/5 core metricsOperating margin changed -5.3 percentage points from the prior annual period.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- Operating margin compressed
Operating margin changed -5.3 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- 2 filing risk checks flagged
Flagged areas: Solvency & liquidity.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Revenue was broadly stable
Latest reported annual revenue changed -0.5% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Free cash flow was positive
Latest reported free cash flow was $219M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-10-22
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Sleep Health$1.38B42.5%+2.1% yoy
- Respiratory Health$691M21.3%+6.1% yoy
- Diabetes Health$592M18.3%-3.6% yoy
- Wellness At Home$583M18.0%-9.8% yoy
Members sum to the consolidated $3.24B for this period.
- Sleep Health$386M52.2%+15.5% yoy
- Respiratory Health$194M26.3%+14.1% yoy
- Wellness At Home$159M21.5%+4.9% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,060 US-listed filers · 314 in Healthcare| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $3.2B | 74thof 3,247 top third | 80thof 285 top third |
Revenue growth latest fiscal-year revenue vs the prior fiscal year | -0.5% | 28thof 3,083 bottom third | 22ndof 270 bottom third |
Operating margin operating income ÷ revenue | 2.8% | 50thof 2,777 middle third | 61stof 274 middle third |
Net margin net income ÷ revenue | -2.2% | 39thof 3,212 middle third | 56thof 284 middle third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | 6.8% | 57thof 2,640 middle third | 63rdof 256 middle third |
Return on equity net income ÷ stockholders' equity (positive equity only) | -4.7% | 37thof 3,520 middle third | 54thof 286 middle third |
Interest coverage operating income ÷ interest expense (interest expense > 0) | 0.9× | 46thof 795 middle third | 59thof 75 middle third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 0.7% | 78thof 2,852 top third | 92ndof 270 top third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 42 days | 60thof 2,373 middle third | 80thof 259 top third |
Net debt ÷ operating cash flow net debt ÷ operating cash flow (OCF > 0) · lower is ranked higher | 2.7× | 43rdof 1,524 middle third | 44thof 115 middle third |
Cash-flow accrual ratio (net income − operating cash flow) ÷ average total assets · lower is ranked higher | -15.3% | 82ndof 3,845 top third | 79thof 299 top third |
Balance-sheet accrual ratio change in net operating assets ÷ average net operating assets · lower is ranked higher | -8.9% | 73rdof 3,301 top third | 73rdof 261 top third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 19 changed periods| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Net income NetIncomeLoss | quarter 2020-03-31 | -$158K 10-Q 2020-05-08 | -$34.6M 10-Q 2021-05-10 | -21745.3% | first · latest · 4 filings carry it |
| Net income NetIncomeLoss | quarter 2020-09-30 | -$2.49M 10-Q 2020-11-06 | -$51M 10-Q 2021-11-09 | -1950.4% | first · latest · 4 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2020-06-30 | $8.49M 10-Q 2020-08-07 | -$58.7M 10-K/A 2021-04-30 | -791.0% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2020-03-31 | -$10.7M 10-Q 2020-05-08 | -$54.1M 10-K/A 2021-04-30 | -407.5% | first · latest · 3 filings carry it |
| Net income NetIncomeLoss | fiscal year 2020-12-31 | -$64.5M 10-K 2021-03-16 | -$162M 10-K 2023-02-28 | -150.7% | first · latest · 4 filings carry it |
| Intangibles IntangibleAssetsNetExcludingGoodwill | balance at 2025-12-31 | $85.1M 10-K 2026-02-24 | $35.8M 10-Q 2026-08-04 | -58.0% | first · latest · 3 filings carry it |
| Stockholders' equity StockholdersEquity | balance at 2020-09-30 | $449M 10-Q 2020-11-06 | $361M 10-K/A 2021-04-30 | -19.5% | first · latest · 3 filings carry it |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax | quarter 2025-06-30 | $800M 10-Q 2025-08-05 | $657M 10-Q 2026-08-04 | -17.9% | first · latest |
| Operating income OperatingIncomeLoss | quarter 2025-06-30 | $79.3M 10-Q 2025-08-05 | $65.7M 10-Q 2026-08-04 | -17.1% | first · latest |
| Stockholders' equity StockholdersEquity | balance at 2020-12-31 | $418M 10-K 2021-03-16 | $355M 10-K 2022-03-01 | -15.2% | first · latest · 6 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2020-03-31 | $9.31M 10-Q 2020-05-08 | $8.22M 10-Q 2021-05-10 | -11.7% | first · latest |
| Net income NetIncomeLoss | quarter 2020-06-30 | $4.03M 10-Q 2020-08-07 | $4.47M 10-Q 2021-08-06 | +10.8% | first · latest · 4 filings carry it |
| Total liabilities Liabilities | balance at 2020-03-31 | $691M 10-Q 2020-05-08 | $765M 10-K/A 2021-04-30 | +10.7% | first · latest · 3 filings carry it |
| Total liabilities Liabilities | balance at 2020-09-30 | $1.11B 10-Q 2020-11-06 | $1.21B 10-K/A 2021-04-30 | +9.2% | first · latest · 3 filings carry it |
| Total liabilities Liabilities | balance at 2020-06-30 | $746M 10-Q 2020-08-07 | $814M 10-K/A 2021-04-30 | +9.1% | first · latest · 3 filings carry it |
| Total liabilities Liabilities | balance at 2020-12-31 | $1.42B 10-K 2021-03-16 | $1.53B 10-K 2022-03-01 | +8.0% | first · latest · 6 filings carry it |
| Operating income OperatingIncomeLoss | quarter 2020-06-30 | $16.5M 10-Q 2020-08-07 | $15.6M 10-Q 2021-08-06 | -5.5% | first · latest |
| Goodwill Goodwill | balance at 2025-12-31 | $2.54B 10-K 2026-02-24 | $2.46B 10-Q 2026-08-04 | -3.3% | first · latest · 3 filings carry it |
| Deferred revenue (current) ContractWithCustomerLiabilityCurrent | balance at 2025-12-31 | $59.8M 10-K 2026-02-24 | $59.3M 10-Q 2026-08-04 | -0.8% | first · latest · 3 filings carry it |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for AHCO yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.